Award Winning Firm Labaton Sucharow Notifies Credit Suisse Group AG (N...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 5, 2023

New Web Addresses Pave the Way for LGBTQ+ Businesses to Thrive and Connect • Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference • Dr. Jen Ashton's "BETTER" Hits Newsstands Nationwide Today • Cupshe Celebrates 8th Birthday with Exclusive Collection in Collaboration with Chanel Iman, Heather Rae El Moussa, and Brittany • Milliken & Company Debuts on Newsweek’s Top 100 Global Most Loved Workplaces • Tips for a smooth transition to senior living from the San Luis Obispo assisted living professionals • Anaergia Signs Contract to Build State-of-the-Art Food Waste and Wastewater Sludge Co-Digestion Facility at Monterey One Water i • Operation Homefront presents Cornerstone Award to Bob Deforge of Pratt & Whitney • Allego Reports First Quarter 2023 Results; Allego Nearly Triples Charging Revenues in Q1 2023 • DANA and Ant Group Announce Local Women Entrepreneur Winners of the Inaugural SisBerdaya Program • Statement by the Prime Minister on Canadian Armed Forces Day • Founders First Capital Partners Sponsors Women in Cloud to Foster Financial Opportunities for Women Tech Founders • U.S. Institute of Peace Opens Nominations for 2023 Women Building Peace Award • Changing dishwashing habits can help save more than 3.5 million tonnes of CO2 in Europe • Dorsett Wanchai Marks World Environment Day 2023 with Bold Paperless and Plastic-Free Sustainability Initiatives • Seneca Therapeutics, Inc. Appoints Cuong Do to its Board of Directors • Lexington Law to Continue Fighting for Clients That Seek Credit Reports That are Fair, Accurate and Supported by Evidence • KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • The Executive Leadership Council Announces the Appointment of Fabian Milburn as Chief Legal and Human Resources Officer • Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β Inhibitor, BCA101, Demonstrates 65% ORR in Combination wi

Award Winning Firm Labaton Sucharow Notifies Credit Suisse Group AG (NYSE: CS) Investors of the Filing of a Securities Class Act

NEW YORK , March 22 /Businesswire/ - Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm, announces a securities class action lawsuit has been filed against Credit Suisse Group AG ("Credit Suisse" or "the Company") (NYSE: CS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

According to the Complaint, the Company made false and misleading statements to the market. Credit Suisse continued to suffer an outflow of customers despite executives' claims that it was no longer losing business. The Company downplayed the negative impact of recent poor performance and compliance failures. The Company overstated its prospects and financial position. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Credit Suisse, investors suffered damages.

Investors who purchased the Company's securities between March 10, 2022 and March 15, 2023, inclusive (the ''Class Period''), are encouraged to contact the firm before May 8, 2023.

If you currently own stock or options in Credit Suisse Group AG and suffered a loss, click here to participate.

If you want to receive additional information and protect your investments free of charge, please contact Labaton Sucharow’s Client Development Group via email at info@labaton.com or (212) 907-0759.

About the Firm

Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, corporate governance and shareholder rights, consumer, and cybersecurity and data privacy litigation, as well as whistleblower representation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at labaton.com.